stockrowRevvity Inc.
RVTY Healthcare Diagnostics & Research
Revvity Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 billion, up 3.67% from fiscal 2024.
- Revenue
- +4.29%
- EPS
- +2.17%
- Free cash flow
- +27.0%
- Total debt
- −18.1%
Quarter to September 2026, against a year earlier
Follow RVTY
Alert me
Revvity Inc. (RVTY) Operating cash flow
Revvity Inc.'s operating cash flow for fiscal 2025 was $582.9M, down 7.22% from $628.3M in fiscal 2024. Over the twelve months to 30 September 2026 it was $655.8M. Over the past ten years it has ranged from $91.3M (fiscal 2023) to $1.4B (fiscal 2021); the current reading is higher than 64% of that period. Revvity Inc. ranks 12th of 49 Diagnostics & Research companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | $582.9M | (7.22%) |
| FY2024 | $628.3M | 588.38% |
| FY2023 | $91.3M | (86.57%) |
| FY2022 | $679.8M | (51.81%) |
| FY2021 | $1.4B | 58.12% |
| FY2020 | $892.2M | 145.46% |
| FY2019 | $363.5M | 16.86% |
| FY2018 | $311.0M | 7.83% |
| FY2017 | $288.5M | (17.73%) |
| FY2016 | $350.6M | 22.12% |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Sep 2026 | $166.7M | (13.15%) |
| Jun 2026 | $191.9M | 66.57% |
| Mar 2026 | $115.2M | (36.67%) |
| Dec 2025 | $182.0M | 31.38% |
| 43 more quarters | Free account |
Against its own ten years
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| DGX Quest Diagnostics Incorporated compare | $2.0B |
| LH Labcorp Holdings Inc. compare | $1.8B |
| ILMN Illumina, Inc. compare | $1.2B |
| ICLR ICON PLC compare | $1.0B |
| MEDP Medpace Holdings, Inc. compare | $723.0M |
| RVTY Revvity Inc. | $655.8M |
| QGEN QIAGEN N.V. compare | $654.5M |
| CRL Charles River Laboratories International, Inc. compare | $622.4M |
| GH Guardant Health, Inc. compare | −$173.5M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on RVTY
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement